Human helper T cell activation and differentiation is suppressed by porcine small intestinal submucosa.
A cell-free biomaterial derived from porcine small intestinal submucosa (SIS) has been used successfully in many models as a xenogeneic scaffolding material without generating immune-mediated inflammatory reactions. We investigated whether this absence of inflammation is due to the presence of porcine transforming growth factor beta (TGF-beta) activity found in SIS that may have immunosuppressive properties on helper T (Th) cell subset activation and differentiation. We used in vitro models for the generation of human Th1 and Th2 cells to investigate the influence of SIS. We found that SIS partially suppressed Th1 cell expansion and secretion of interleukin 12 (IL-12) and interferon gamma (IFN-gamma) in a TGF-beta-dependent manner, but Th1 cell expansion and IFN-gamma secretion could be fully overcome by addition of recombinant IL-12. The suppression by SIS of Th cell activation also involved the induction of Th cell apoptosis. In addition, SIS completely abolished the generation of Th2 cells in vitro, but this effect of SIS was not reversed by neutralizing TGF-beta antibodies. Our results indicate the presence in SIS of factors that can suppress Th cell activation through both the inhibition of IL-12 secretion and the induction of Th cell apoptosis. We established further that these factors include TGF-beta and at least one other factor.
Palmer
Ellen M
EM
Department of Environmental Health, Boston University School of Public Health, 715 Albany Street, Boston, MA 02118, USA.
Beilfuss
Beth A
BA
Nagai
Taro
T
Semnani
Roshanak T
RT
Badylak
Steve F
SF
van Seventer
Gijs A
GA
D000276:Adjuvants, Immunologic / Q000494:pharmacology; D000818:Animals; D002454:Cell Differentiation / Q000502:physiology*; D005109:Extracellular Matrix / Q000502:physiology*; D006801:Humans; D018664:Interleukin-12 / Q000494:pharmacology; D007421:Intestine, Small / Q000378:metabolism*; D013552:Swine; D006377:T-Lymphocytes, Helper-Inducer / Q000187:drug effects / Q000502:physiology*; D016212:Transforming Growth Factor beta / Q000378:metabolism
D000276:Adjuvants, Immunologic; D016212:Transforming Growth Factor beta; D018664:Interleukin-12